A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine safety, tolerability, and pharmacokinetics of GRT7040 in healthy volunteers
HP7040-01
Phase 1 other active
Quick answer
A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine safety, tolerability, and pharmacokinetics of GRT7040 in healthy volunteers for Treatment of pain is a Phase 1 program (other) at Gruenenthal GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gruenenthal GmbH
- Indication
- Treatment of pain
- Phase
- Phase 1
- Modality
- other
- Status
- active